Matches in SemOpenAlex for { <https://semopenalex.org/work/W1897527580> ?p ?o ?g. }
- W1897527580 abstract "Background Long‐acting ß2‐ agonists (LABA) in combination with inhaled corticosteroids (ICS) are increasingly prescribed in asthmatic children. Objectives To compare the safety and benefit of adding LABA to ICS with the same or an increased dose of ICS in children with persistent asthma. Search methods We searched the Cochrane Airways Group Asthma Trials Register (May 2008). Selection criteria We included randomised controlled trials testing the combination of LABA and ICS versus the same or an increased dose of ICS for minimum of at least 28 days in children and adolescents with asthma. The main outcome was the rate of exacerbations requiring rescue oral steroids. Secondary outcomes included pulmonary function, symptoms, adverse events, and withdrawals. Data collection and analysis Studies were assessed independently by two review authors for methodological quality and data extraction. Confirmation was obtained from the trialists when possible. Main results A total of 25 trials representing 31 control‐intervention comparisons were included in the review randomising 5572 children. Most of the participants were inadequately controlled on current ICS dose. We assessed the addition of LABA to the same dose of ICS and to an increased dose of ICS: (1) The addition of LABA to ICS was compared to same dose ICS, namely 400 mcg/day of beclomethasone or less in 16 of the 24 studies. The mean age of participants was 10 years and males accounted for 64% of the study populations. The mean FEV1 at baseline was 80% of predicted or above in 10 studies; FEV1 61% to 79% of predicted in eight studies; and unreported in the remaining study. Participants were inadequately controlled before randomisation in all but seven studies. Compared to ICS alone, the addition of LABA to ICS was not associated with a significant reduction in exacerbations requiring oral steroids (seven studies, RR 0.92 95% CI 0.60 to 1.40). Compared to ICS alone, there was a significantly greater improvement in FEV1 with the addition of LABA (nine studies; 0.08 Litres, 95% CI 0.06 to 0.11) but no statistically significant group differences in symptom‐free days, hospital admission, quality of life, use of reliever medication, and adverse events. Withdrawals occurred significantly less frequently with the addition of LABA. (2) A total of seven studies assessed the addition of LABA to ICS therapy compared with an increased dose of ICS randomising 1021 children. The mean age of participants was 8 years with 67% of males. The baseline mean FEV1 was 80% of predicted or above in 2 of the 3 studies reporting this characteristic. All trials enrolled participants who were inadequately controlled on a baseline dose equivalent to 400 mcg/day of beclomethasone or less. There was no group significant difference in the risk of an exacerbation requiring oral steroids with the combination of LABA and ICS compared to a double dose of ICS (two studies, RR 1.5 95% CI 0.65 to 3.48). The increased risk of hospital admission with combination therapy was also not statistically significant (RR 2.21 95% CI 0.74 to 6.64). Compared to double dose ICS, use of LABA was associated with a significantly greater improvement in morning PEF (four studies; MD 7.55 L/min 95% CI: 3.57 to 11.53) and evening PEF L/min (three studies, MD 5.5 L/min; 95% CI 1.21 to 9.79), but there were insufficient data to aggregate data on FEV1, symptoms, rescue reliever use, and quality of life. There was no statistically significant difference in the overall risk of all cause withdrawals (five studies; RR 0.71; 95% CI 0.42 to 1.20. There was no group difference in the risk of overall adverse effects detected. Short term growth was significantly greater in children treated with combination therapy compared to double dose ICS (two studies: MD 1.2 cm/year; 95% CI 0.72 to 1.7). Authors' conclusions In children with persistent asthma, the addition of LABA to ICS was not associated with a significant reduction in the rate of exacerbations requiring systemic steroids, but was superior for improving lung function compared to the same dose of ICS. Similarly, compared to a double dose ICS, the combination of LABA and ICS did not significantly increase the risk of exacerbations requiring oral steroids, but was associated with a significantly greater improvement in PEF and growth. The possibility of an increased risk of rescue oral steroids and hospital admission with LABA therapy needs to be further examined." @default.
- W1897527580 created "2016-06-24" @default.
- W1897527580 creator A5026811956 @default.
- W1897527580 creator A5034261245 @default.
- W1897527580 creator A5037509074 @default.
- W1897527580 creator A5056412174 @default.
- W1897527580 creator A5065533338 @default.
- W1897527580 date "2009-07-08" @default.
- W1897527580 modified "2023-10-02" @default.
- W1897527580 title "Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children" @default.
- W1897527580 cites W1530703935 @default.
- W1897527580 cites W1543855637 @default.
- W1897527580 cites W1559467617 @default.
- W1897527580 cites W1593822197 @default.
- W1897527580 cites W1596818240 @default.
- W1897527580 cites W1598602811 @default.
- W1897527580 cites W1626773437 @default.
- W1897527580 cites W1795103282 @default.
- W1897527580 cites W1807048566 @default.
- W1897527580 cites W1897527580 @default.
- W1897527580 cites W1903824044 @default.
- W1897527580 cites W1906463009 @default.
- W1897527580 cites W1917912133 @default.
- W1897527580 cites W1929125794 @default.
- W1897527580 cites W1929605331 @default.
- W1897527580 cites W1931016737 @default.
- W1897527580 cites W1962391690 @default.
- W1897527580 cites W1965221209 @default.
- W1897527580 cites W1965797594 @default.
- W1897527580 cites W1971145825 @default.
- W1897527580 cites W1971986623 @default.
- W1897527580 cites W1973764452 @default.
- W1897527580 cites W1974644571 @default.
- W1897527580 cites W1986323240 @default.
- W1897527580 cites W1987571032 @default.
- W1897527580 cites W1987710330 @default.
- W1897527580 cites W1990444499 @default.
- W1897527580 cites W1991112399 @default.
- W1897527580 cites W199806695 @default.
- W1897527580 cites W2001057495 @default.
- W1897527580 cites W2010176815 @default.
- W1897527580 cites W2011487006 @default.
- W1897527580 cites W2012700480 @default.
- W1897527580 cites W2013648491 @default.
- W1897527580 cites W2014186397 @default.
- W1897527580 cites W2014369144 @default.
- W1897527580 cites W2017601887 @default.
- W1897527580 cites W2020544746 @default.
- W1897527580 cites W2027543843 @default.
- W1897527580 cites W2033432863 @default.
- W1897527580 cites W2034106034 @default.
- W1897527580 cites W2035762677 @default.
- W1897527580 cites W2037952886 @default.
- W1897527580 cites W2039383868 @default.
- W1897527580 cites W2041672216 @default.
- W1897527580 cites W2043740276 @default.
- W1897527580 cites W2045002632 @default.
- W1897527580 cites W2045449026 @default.
- W1897527580 cites W2045868513 @default.
- W1897527580 cites W2046509044 @default.
- W1897527580 cites W2046906589 @default.
- W1897527580 cites W2049412625 @default.
- W1897527580 cites W2050399966 @default.
- W1897527580 cites W2056765271 @default.
- W1897527580 cites W2062794121 @default.
- W1897527580 cites W2063905372 @default.
- W1897527580 cites W2066060939 @default.
- W1897527580 cites W2068455992 @default.
- W1897527580 cites W2069105771 @default.
- W1897527580 cites W2070646431 @default.
- W1897527580 cites W2072271497 @default.
- W1897527580 cites W2074251930 @default.
- W1897527580 cites W2075917967 @default.
- W1897527580 cites W2079645048 @default.
- W1897527580 cites W2081360527 @default.
- W1897527580 cites W2083121402 @default.
- W1897527580 cites W2084679421 @default.
- W1897527580 cites W2090495361 @default.
- W1897527580 cites W2091215885 @default.
- W1897527580 cites W2092919059 @default.
- W1897527580 cites W2092982642 @default.
- W1897527580 cites W2095324820 @default.
- W1897527580 cites W2096043817 @default.
- W1897527580 cites W2097899043 @default.
- W1897527580 cites W2097981132 @default.
- W1897527580 cites W2099652899 @default.
- W1897527580 cites W2101864423 @default.
- W1897527580 cites W2102627080 @default.
- W1897527580 cites W2103665631 @default.
- W1897527580 cites W2107328434 @default.
- W1897527580 cites W2109613186 @default.
- W1897527580 cites W2110658984 @default.
- W1897527580 cites W2112894410 @default.
- W1897527580 cites W2113552278 @default.
- W1897527580 cites W2113934803 @default.
- W1897527580 cites W2116173647 @default.
- W1897527580 cites W2117955239 @default.
- W1897527580 cites W2119011882 @default.
- W1897527580 cites W2119187710 @default.
- W1897527580 cites W2121545123 @default.